Celyad (Belgium).
They have one cardiac product: C-Cure. This is BM stem cells differentiated into cardiac progenitor cells and then injected into the heart for cardiac regeneration (I guess after a heart attack). This product is in phase II.
They also have an immuno-oncology product: NKG2D. This is a Natural Killer based cell product fitted with a CAR-T receptor. Phase I.
The news item is that they gathered a scientific advisory board of ~10 experts in immuno-oncology (link).
